Cyagen Biosciences-preview

Cyagen

Cyagen Biosciences

Private

Santa Clara, CaliforniaHealthcare & Life Scienceshttps://www.cyagen.com/

Last Round

Series B

Feb 26, 2020

Total Funding Raised

$40.6M

Company Overview

Cyagen Biosciences is a biotechnology company that provides genetically modified rodent models and contract research organization (CRO) solutions for biomedical research and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

contract research organizationCROcustom mouse modelsgenetically modified modelsrodent modelsGEMMknockout mouse modelshumanized mouse modelspreclinical CRO servicescustom cell line modelscell line engineeringdisease modelsvector constructionvirus packaging servicesAI antibody discoveryTurboKnockout

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cyagen Biosciences Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cyagen Biosciences Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Feb 26, 2020
Series A	Aug 11, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Reza Rezaei

Chief Executive Officer

Executive Team

Cyagen Biosciences Investors

Notable investors and investment history

Investor	Rounds
GF Xinde Investment Management	Series B
China Merchants Zhiyuan Capital Investment Co., Ltd.	Series B
LYFE Capital	Series A
Grower Venture Capital	Series B
GF Qianhe Investment Co., Ltd.	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 7, 2025
Monthly visitors increased 48% MoM.
May 2, 2025
Monthly visitors increased 91% MoM to 58.5K.

View all signals

Cyagen Biosciences Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cyagen Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cyagen Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California

Employee Range134

Year Founded2006

Last FundingFeb 26, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.